Skip to main content

Table 5 Survival

From: Changing the clinical course of glioma patients by preoperative motor mapping with navigated transcranial magnetic brain stimulation

  nTMS non-nTMS p-value
All tumors Overall survival (months) 15.7 ± 10.9 11.9 ± 10.3 0.1310
3 months survival rate (%) 93.7 80.9 0.0298
6 months survival rate (%) 88.5 62.7 0.0015
9 months survival rate (%) 72.9 50.7 0.0167
12 months survival rate (%) 58.7 40.3 0.0544
WHO grade III Overall survival (months) 21.5 ± 9.0 7.2 ± 3.6 0.0322
3 months survival rate (%) 100.0 100.0 1.000
6 months survival rate (%) 100.0 84.6 0.1410
9 months survival rate (%) 91.7 76.9 0.3151
12 months survival rate (%) 80.0 69.2 0.5598
WHO grade IV Overall survival (months) 15.1 ± 11.1 12.4 ± 10.6 0.3196
3 months survival rate (%) 91.8 76.4 0.0332
6 months survival rate (%) 84.6 57.4 0.0052
9 months survival rate (%) 66.7 44.4 0.0384
12 months survival rate (%) 52.8 33.3 0.0663
  1. Detailed survival data including mean overall survival, 3, 6, 9, and 12 months survival rates for all tumor patients and separately for WHO grade III and IV tumor patients of both groups.